
|Articles|November 1, 2011
- Pharmaceutical Executive-11-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2011
Red Light on the Access Autobahn
Advertisement
Articles in this issue
over 14 years ago
Plant Managementover 14 years ago
The Road from No. 20over 14 years ago
Five Yearsover 14 years ago
Spotlight on OTCsover 14 years ago
Invarover 14 years ago
Europe Tackles 'Advertising in Disguise' Fearsover 14 years ago
The Drug Shortages Struggleover 14 years ago
Euroserviceover 14 years ago
Pharma's Visit to the Plastic Surgeonover 14 years ago
The Pharma Revolution RecalibratedAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5




